BiotechTube
Home/Geron/Anil Kapur
AK

Anil Kapur

Executive Vice President, Corporate Strategy and Chief Commercial Officer

Geron

Therapeutic Areas

Hematologic MalignanciesMyeloid Cancers

Geron Pipeline

DrugIndicationPhase
Imetelstat (Rytelo™)Transfusion-Dependent Anemia in Lower-Risk Myelodysplastic Syndromes (MDS)Approved
ImetelstatJAK Inhibitor Relapsed/Refractory Myelofibrosis (MF)Phase 3
Imetelstat + RuxolitinibFrontline Myelofibrosis (MF)Phase 1
Imetelstat + Azacitidine ± VenetoclaxRelapsed/Refractory Acute Myeloid Leukemia (R/R AML)Phase 1

Leadership Team at Geron

JA
John A. Scarlett, M.D.
Chief Executive Officer and Chairman
AJ
Andrew J. Grethlein, Ph.D.
Executive Vice President and Chief Operating Officer
FF
Faye Feller, M.D.
Executive Vice President and Chief Medical Officer
MR
Michelle Robertson
Executive Vice President and Chief Financial Officer
View full Geron profile